NUKARIOPriority claimed from 27/04/2023; Application No. : 97910214 ;United States of America (Class 5)
#6164466
Application Number:6164466
Status:
Unknown
Class:5
Applicant: GENZYME CORPORATION
Filing Date:Thu, 26 Oct 2023
Get a free email alert the moment this application's status changes.
Trademark Information
| Trademark | NUKARIOPriority claimed from 27/04/2023; Application No. : 97910214 ;United States of America |
| Trademark Type | Wordmark |
| Class | 5 |
| Application Number | 6164466 |
| Nature/Scope of business | Pharmaceutical products for the prevention and treatment of immunological diseases, pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders, pharmaceutical preparations for the treatment of Amyotrophic Lateral Sclerosis and Multiple Sclerosis and Alzheimer’s |
| Publication | In Journal No. 2134 |
| Status | Unknown |
| Applicant: | GENZYME CORPORATION |
| Applicant Address | 450 Water Street, CAMBRIDGE, MA 02141, UNITED STATES OF AMERICA A Massachusetts corporation, USA |
| Jurisdiction | DELHI |
| Agent | REMFRY & SAGAR |
| Agent Address | REMFRY HOUSE AT THE MILLENNIUM PLAZA SEC 27, GURGAON 122009, NEW DELHI NATIONAL CAPITAL REGION INDIA |
Frequently Asked Questions
Who is the owner of trademark NUKARIOPriority claimed from 27/04/2023; Application No. : 97910214 ;United States of America? ▾
The trademark application number 6164466 is owned by GENZYME CORPORATION.
Which class does trademark NUKARIOPriority claimed from 27/04/2023; Application No. : 97910214 ;United States of America belong to? ▾
Trademark application number 6164466 is filed under Class 5, which relates to the specified goods and services.
Who is the trademark agent for application 6164466? ▾
The trademark agent associated with application number 6164466 is REMFRY & SAGAR.
Was trademark NUKARIOPriority claimed from 27/04/2023; Application No. : 97910214 ;United States of America published in the journal? ▾
Yes, trademark application number 6164466 was published in Journal No. 2134.
What is trademark NUKARIOPriority claimed from 27/04/2023; Application No. : 97910214 ;United States of America? ▾
Trademark application number 6164466 relates to "Pharmaceutical products for the prevention and treatment of immunological diseases, pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders, pharmaceutical preparations for the treatment of Amyotrophic Lateral Sclerosis and Multiple Sclerosis and Alzheimer’s".
File Trademark at Just ₹1,499 + Govt Fees
Get your trademark registered with expert guidance. Limited time offer!
File NowExpert Consultation
Quick Processing
100% Support
Free Report
Get Detailed Trademark Report
Comprehensive analysis of your trademark search delivered to your phone
What you'll get:
- Complete trademark analysis
- Conflict assessment
- Registration guidance
15,000+Trademarks Filed
98%Success Rate
Govt Authorized
ISO Certified